This observation, added to the safer metabolic profile of IGF-1, with a lower liver hypertrophic effect and a higher histological response regarding steatosis, suggests that direct supplementation with IGF-1 presents a more attractive therapeutic profile than supplementation with GH. This evidence concerns the gene IGF1 and steatosis.